NCT03055936View on ClinicalTrials.gov

Dose-finding Pharmacokinetic Study in Healthy Males

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 21, 2017

Primary Completion Date

June 9, 2017

Study Completion Date

June 9, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

Levodopa

Levodopa 50 mg or 100 mg or 150 mg

DRUG

Carbidopa

Carbidopa 12.5 mg or 25 mg or 65 mg

DRUG

ODM-104

ODM-104 50 mg or 100 mg

Trial Locations (1)

89231

Nuvisan Pharma Services, Neu-Ulm

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT03055936 - Dose-finding Pharmacokinetic Study in Healthy Males | Biotech Hunter | Biotech Hunter